THE ULTIMATE GUIDE TO RO5256390

quinupristin/dalfopristin will improve the degree or impact of avanafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. CYP3A4 inhibitors may possibly lessen avanafil clearance escalating systemic exposure to avanafil; greater degrees may possibly end in enhanced related adverse activities; the most proposed do